Eisai (Rights to Salagen and Panretin)

Business Data, Corporate Office and Headquarter Address

About

Eisai (Rights to Salagen and Panretin) is Buildings and Property in Japan that focus on hypofunction treatment medicines business. They cover business area such as gland hypofunction.

Business Type

Buildings and Property

Country

Japan

Founded

-

Company Focus

Hypofunction Treatment Medicines

Website

-

Corporate Office and Headquarter Office address:

4-6-10 Koishikawa
Bunkyo-ku
Tokyo, 112-8088
Japan

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

gland hypofunction

* We use standard office opening hours in near Eisai (Rights to Salagen and Panretin)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Eisai (Rights to Salagen and Panretin) Frequently Asked Questions

What or who is Eisai (Rights to Salagen and Panretin)?

Eisai (Rights To Salagen And Panretin) is Buildings and Property business from Japan that founded in - ( years old in ), Eisai (Rights to Salagen and Panretin) business is focusing on Hypofunction Treatment Medicines.

Where is Eisai (Rights to Salagen and Panretin) headquarter and corporate office address?

Eisai (Rights to Salagen and Panretin) headquarter office and corporate office address is located in 4-6-10 Koishikawa Bunkyo-ku Tokyo, 112-8088 Japan.

Where is Eisai (Rights to Salagen and Panretin) country origins?

Eisai (Rights to Salagen and Panretin) was founded in Japan.

What is Hypofunction Treatment Medicines business focus on?

In , Eisai (Rights to Salagen and Panretin) is currently focus on hypofunction treatment medicines sector.

Hypofunction Treatment Medicines Business Interest from Google Trend

Above is snippet of Google Trends for "hypofunction treatment medicines" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Eisai (Rights to Salagen and Panretin), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.